Final Analysis of the ECOG I-Copa Trial (E6484) in Patients With Non-Hodgkin’s Lymphoma Treated With Interferon Alfa (IFN-α2a) Plus an Anthracycline-Based Induction Regimen

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin’s Lymphoma in Iran

Iranian Journal of Cancer Prevention
2015English

Anthracycline Versus Non-Anthracycline Induction Regimens in Patients With De Novo Acute Myeloid Leukemia

Middle East Journal of Internal Medicine
2017English

Patterns of Glucose Fluctuation Are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

International Journal of General Medicine
Medicine
2020English

Unexpected Echocardiographic Findings in Patients With Non-Hodgkin’s Lymphoma – Asymptomatic Myxoma

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Characteristics and Outcomes of Non-Hodgkin’s Lymphoma Patients With Leptomeningeal Metastases

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2018English

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Hepatitis C Virus Markers in Patients With Acute Post-Transfusion Hepatitis Treated With Interferon Alfa-2b.

Gut
Gastroenterology
1993English

Non-Neoformans Cryptococcemia in a Patient With Hodgkin’s Lymphoma

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy